XenoPort engages in the development and commercialization of drugs for the treatment of neurological and other disorders.
Business Model:
Revenue: $48.2M
Employees: 501-1,000
XenoPort was acquired by
Arbor Pharmaceuticals.
The acquisition happend on 2016-05-20.
Details of the transaction were not public
Address: 3410 Central Expy
City: Santa Clara
State: CA
Zip: 95051
Country: US
XenoPort engages in the development and commercialization of drugs for the treatment of neurological and other disorders.
Contact Phone:
+14086167200
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/20/2005
Ticker Symbol:
XNPT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2004 | Series D | 1 | $25M |
GGV Capital GGV Capital GGV Capital GGV Capital |
11/2012 | Post-IPO Equity | $20M | 6/2002 | Series B | 2 | $43.9M |
Venrock ARCH Venture Partners Venrock Venrock ARCH Venture Partners Venrock |
10/2001 | Grant | $2M | 6/2005 | IPO | $52.5M |
|
2/2000 | Series A | 6 | $15.9M |
Frazier Healthcare Partners Venrock Skyline Ventures Alejandro Zaffaroni CMEA Ventures ARCH Venture Partners Frazier Healthcare Partners Venrock Skyline Ventures Alejandro Zaffaroni CMEA Ventures |
1/2004 | Series C | 2 | $37M |
GGV Capital Venrock GGV Capital Venrock |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|